Prof. Dr. Cornelia Halin Winter

Cornelia Halin Winter is a Full Professor of Pharmaceutical Immunology at the Institute of Pharmaceutical Sciences of ETH Zurich.

Cornelia Halin’s research interests lie at the crossroads of immunology and vascular biology. Her main research focus lies in elucidating the basic mechanisms and significance of leukocyte migration through afferent lymphatic vessels. Moreover, her team seeks to identify new therapeutic targets for the treatment of disorders that involve the (lymphatic) vasculature.

Cornelia Halin was born and raised in Zurich, Switzerland. From 1993 to 1998 she studied biochemistry at ETH Zurich. After obtaining her diploma, she spent 6 months working as an intern in the Department of Molecular Oncology at Genentech Inc., San Francisco USA. She performed her PhD thesis with Dario Neri at ETH Zurich, working in the field of antibody engineering and targeted tumor therapy. After her dissertation in 2002, she joined the lab of Ulrich von Andrian at Harvard Medical School, Boston, USA, for a postdoc in the field of leukocyte trafficking. She returned to ETH Zurich in 2005 for a second postdoc and subsequent senior scientist position in the group of Michael Detmar at the Institute of Pharmaceutical Sciences, where she started to investigate lymphatic vessel biology. As of 2008, she worked as an Assistant Professor at the Institute of Pharmaceutical Sciences of ETH. In 2014 she was appointed Associate Professor and in 2022 promoted to Full Professor.